THE PrEP SURVEY
This month, on behalf of Teva Pharmaceuticals Ireland, we asked our readers online to participate in a survey that examined a number of areas in relation to PrEP, such as sexual health, sexually transmitted infections (STIs), attitudes around HIV, and awareness and use of PrEP amongst the LGBT+ community.
There were 622 respondents to the survey, of which 97% were male. Pre-Exposure Prophylaxis (PrEP), a medication shown to dramatically reduce the risk of contracting HIV (over 85%), was made available, on private prescription, through Irish pharmacies last December for the first time.